Yongwhan Choi

594 total citations
8 papers, 472 citations indexed

About

Yongwhan Choi is a scholar working on Biomaterials, Biomedical Engineering and Immunology. According to data from OpenAlex, Yongwhan Choi has authored 8 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 7 papers in Biomedical Engineering and 4 papers in Immunology. Recurrent topics in Yongwhan Choi's work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Immunotherapy and Immune Responses (3 papers). Yongwhan Choi is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Immunotherapy and Immune Responses (3 papers). Yongwhan Choi collaborates with scholars based in South Korea, United States and Germany. Yongwhan Choi's co-authors include Ick Chan Kwon, Jooho Park, Hyeyoun Chang, Ju Hee Ryu, Wooram Um, Kwangmeyung Kim, Hong Yeol Yoon, Jeongrae Kim, Yujeong Moon and Man Kyu Shim and has published in prestigious journals such as Journal of Controlled Release, Theranostics and Expert Opinion on Drug Delivery.

In The Last Decade

Yongwhan Choi

8 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongwhan Choi South Korea	8	277	271	171	63	60	8	472
Hayley Nehoff New Zealand	3	221 0.8×	272 1.0×	165 1.0×	43 0.7×	66 1.1×	3	466
Shengsheng Cai China	8	315 1.1×	200 0.7×	143 0.8×	62 1.0×	81 1.4×	10	446
Yingwen Hu China	11	230 0.8×	295 1.1×	206 1.2×	45 0.7×	64 1.1×	15	568
Chad A. Walden United States	6	168 0.6×	219 0.8×	163 1.0×	36 0.6×	85 1.4×	6	442
Stefan M. Mladjenovic Canada	7	258 0.9×	249 0.9×	194 1.1×	71 1.1×	90 1.5×	10	545
Eric M. Mastria United States	8	153 0.6×	236 0.9×	149 0.9×	60 1.0×	46 0.8×	12	499
Xuechao Jin China	8	224 0.8×	167 0.6×	133 0.8×	131 2.1×	55 0.9×	8	464
Matthew T. Haynes United States	8	227 0.8×	210 0.8×	239 1.4×	70 1.1×	61 1.0×	10	458
Zu-Qi Zuo China	7	240 0.9×	236 0.9×	230 1.3×	76 1.2×	37 0.6×	7	504
Feiyang Jin China	10	245 0.9×	117 0.4×	134 0.8×	98 1.6×	55 0.9×	14	424

Countries citing papers authored by Yongwhan Choi

Since Specialization

Citations

This map shows the geographic impact of Yongwhan Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongwhan Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongwhan Choi more than expected).

Fields of papers citing papers by Yongwhan Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongwhan Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongwhan Choi. The network helps show where Yongwhan Choi may publish in the future.

Co-authorship network of co-authors of Yongwhan Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Yongwhan Choi. A scholar is included among the top collaborators of Yongwhan Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongwhan Choi. Yongwhan Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Kim, Jeongrae, Yongwhan Choi, Suah Yang, et al.. (2022). Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses. Pharmaceutics. 14(3). 474–474. 23 indexed citations

Kim, Jeongrae, Yongwhan Choi, Dong‐Hwee Kim, Hong Yeol Yoon, & Kwangmeyung Kim. (2022). Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy. Pharmaceutics. 14(9). 1908–1908. 22 indexed citations

Shim, Man Kyu, Suah Yang, Jooho Park, et al.. (2022). Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity. Journal of Nanobiotechnology. 20(1). 436–436. 19 indexed citations

Choi, Yongwhan, Hong Yeol Yoon, Jeongrae Kim, et al.. (2020). Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death. Pharmaceutics. 12(12). 1165–1165. 49 indexed citations

Choi, Yongwhan, Hyounkoo Han, Sangmin Jeon, et al.. (2020). Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound. Pharmaceutics. 12(10). 974–974. 29 indexed citations

Choi, Yongwhan, Seungho Lim, Hong Yeol Yoon, et al.. (2019). Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics. Expert Opinion on Drug Delivery. 16(8). 835–846. 11 indexed citations

Park, Jooho, Yongwhan Choi, Hyeyoun Chang, et al.. (2019). Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment. Theranostics. 9(26). 8073–8090. 296 indexed citations

Chang, Hyeyoun, Ji Young Yhee, Gun Jang, et al.. (2016). Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafish. Journal of Controlled Release. 244(Pt B). 205–213. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact